FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 119 filers reported holding FATE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,065 | -62.8% | 35,408 | 0.0% | 0.00% | – |
| Q2 2023 | $201,827 | 0.0% | 35,408 | 0.0% | 0.00% | – |
| Q1 2023 | $201,827 | -74.4% | 35,408 | -54.7% | 0.00% | – |
| Q4 2022 | $788,544 | -100.0% | 78,151 | -81.0% | 0.00% | -100.0% |
| Q3 2022 | $9,208,111,000 | -27.7% | 410,893 | -20.1% | 0.01% | -28.6% |
| Q2 2022 | $12,739,325,000 | -26.0% | 514,097 | +15.8% | 0.01% | 0.0% |
| Q1 2022 | $17,215,818,000 | -31.1% | 444,050 | +3.9% | 0.01% | -30.0% |
| Q4 2021 | $25,003,838,000 | +17.4% | 427,343 | +18.9% | 0.01% | +11.1% |
| Q3 2021 | $21,302,173,000 | -28.6% | 359,409 | +4.6% | 0.01% | -30.8% |
| Q2 2021 | $29,818,181,000 | +20.7% | 343,567 | +14.7% | 0.01% | +18.2% |
| Q1 2021 | $24,701,442,000 | -33.8% | 299,593 | -27.0% | 0.01% | -35.3% |
| Q4 2020 | $37,319,945,000 | +64.5% | 410,425 | -27.7% | 0.02% | +41.7% |
| Q3 2020 | $22,684,414,000 | +18.7% | 567,536 | +1.9% | 0.01% | 0.0% |
| Q2 2020 | $19,113,208,000 | +134.8% | 557,074 | +52.0% | 0.01% | +100.0% |
| Q1 2020 | $8,141,231,000 | -24.6% | 366,557 | -33.5% | 0.01% | -14.3% |
| Q4 2019 | $10,792,777,000 | +26.1% | 551,496 | +0.0% | 0.01% | +16.7% |
| Q3 2019 | $8,561,317,000 | -21.7% | 551,276 | +2.3% | 0.01% | -25.0% |
| Q2 2019 | $10,940,299,000 | +17.1% | 538,931 | +1.4% | 0.01% | +14.3% |
| Q1 2019 | $9,341,986,000 | +41.8% | 531,701 | +3.5% | 0.01% | +16.7% |
| Q4 2018 | $6,588,257,000 | +514.8% | 513,504 | +680.7% | 0.01% | +500.0% |
| Q3 2018 | $1,071,524,000 | – | 65,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |